** Shares of Kleenex tissue maker Kimberly-Clark KMB.N down 1.1% at $129.95 premarket
** Co's Q4 adjusted EPS of $1.50 narrowly misses estimates of $1.51 - data compiled by LSEG
** Q4 revenue falls 1.8% to $4.93 billion, but beats estimates of $4.86 billion
** Co also sees adjusted EPS for fiscal 2025 to rise by mid-to-high single-digits compared with estimates of 3.2% increase
** KMB rose ~8% in 2024
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。